| CXSB2000040 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-08-12 | 海正药业（杭州）有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2020-12-09 | view |
| CXSL1800028 | 重组抗PD-L1全人源单克隆抗体注射液 | Recombinant anti-PD-L1 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-03-26 | 海正药业（杭州）有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2018-08-07 | view |
| CXSL1700097 | 注射用重组抗IgE人源化单克隆抗体 | | Lyophilized | Biological Products(2) | New Drug Application | 2017-10-19 | 海正药业（杭州）有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2018-10-22 | view |
| CXSL1600073 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(7) | New Drug Application | 2016-10-08 | 海正药业（杭州）有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2017-12-21 | view |
| CXSL1500025 | 重组抗白介素-6受体人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2015-05-05 | 海正药业（杭州）有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2016-11-09 | view |
| CYHS1201621 | 吗替麦考酚酯 | mycophenolate mofetil | Active ingredient | Chemical Drugs(6) | Generic Drug | 2013-04-12 | 海正药业（杭州）有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2017-10-20 | view |
| CXHS1100081 | 达托霉素 | daptomycin | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2011-11-10 | 海正药业（杭州）有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2015-11-19 | view |
